Literature DB >> 33826526

Answer to March 2021 Photo Quiz.

Hugh Adler1,2, James Cruise3, Jun Yong4, Amit Patel4,5, Magda Mikhail6, Michael B J Beadsworth3,2, Nicholas J Beeching1,2,7.   

Abstract

Keywords:  acute myelogenous leukemia; maribavir; varicella-zoster virus

Year:  2021        PMID： 33826526      PMCID： PMC8106698          DOI： 10.1128/JCM.00119-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  6 in total

1.  Image of the month: the three Ms of herpetic infection.

Authors: 
Journal:  Am J Gastroenterol       Date:  2011-12       Impact factor: 10.864

2.  Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.

Authors:  Y Koc; K B Miller; D P Schenkein; J Griffith; M Akhtar; J DesJardin; D R Snydman
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

3.  Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.

Authors:  C B Steer; J Szer; J Sasadeusz; J P Matthews; J A Beresford; A Grigg
Journal:  Bone Marrow Transplant       Date:  2000-03       Impact factor: 5.483

Review 4.  Ecthyma gangrenosum and ecthyma-like lesions: review article.

Authors:  M Vaiman; T Lazarovitch; L Heller; G Lotan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-19       Impact factor: 3.267

5.  Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.

Authors:  Michael Boeckh; Hyung W Kim; Mary E D Flowers; Joel D Meyers; Raleigh A Bowden
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

6.  Infection with varicella-zoster virus after marrow transplantation.

Authors:  R M Locksley; N Flournoy; K M Sullivan; J D Meyers
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.